Profile of prostanoid release following antigen challenge in vivo in the skin of man
暂无分享,去创建一个
A. Kagey‐Sobotka | L. Lichtenstein | M. C. Liu | W. Hubbard | P. Cooper | W. Massey | L. M. Lichtenstein | M. Liu | ANNE KAGEY‐SOBOTKA | A. Kagey-sobotka
[1] L. Lichtenstein,et al. Interleukin-1 is released at sites of human cutaneous allergic reactions. , 1990, The Journal of allergy and clinical immunology.
[2] E. Bleecker,et al. Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. , 1990, The American review of respiratory disease.
[3] J. Cohen,et al. Pro‐inflammatory mediators induce sustained release of prostaglandin E2 from human dermal microvascular endothelial cells , 1990, The British journal of dermatology.
[4] A. Kagey‐Sobotka,et al. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. , 1989, The Journal of clinical investigation.
[5] L. Roberts,et al. Transformation of prostaglandin D2 to isomeric prostaglandin F2 compounds by human eosinophils. A potential mast cell-eosinophil interaction. , 1988, Journal of immunology.
[6] A. Black,et al. The release of prostaglandin D2 from human skin in vivo and in vitro during immediate allergic reactions , 1988, British journal of pharmacology.
[7] L. Lichtenstein,et al. Prostaglandin D2 and histamine during the immediate and the late-phase components of allergic cutaneous responses. , 1988, The Journal of allergy and clinical immunology.
[8] J. Warner,et al. Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity. , 1987, Journal of immunology.
[9] S. Holgate,et al. Prostaglandin D2 release from human skin mast cells in response to ionophore A23187 , 1987, British journal of pharmacology.
[10] P. O'Byrne,et al. Late asthmatic responses. , 1987, The American review of respiratory disease.
[11] S. Holgate,et al. 9 alpha,11 beta-prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways. , 1987, The Journal of clinical investigation.
[12] R. Naclerio,et al. Arachidonic acid metabolites during nasal challenge. , 1987, Archives of otolaryngology--head & neck surgery.
[13] A. Togias,et al. Observations on nasal late phase reactions. , 1987, Immunological investigations.
[14] C. Dollery,et al. Prostaglandin D2 and histamine release in cold urticaria. , 1986, The Journal of allergy and clinical immunology.
[15] P. Wong,et al. Hepatic transformation of prostaglandin D2 to a new prostanoid, 9 alpha,11 beta-prostaglandin F2, that inhibits platelet aggregation and constricts blood vessels. , 1985, The Journal of biological chemistry.
[16] L. Roberts,et al. Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[17] S. Holgate,et al. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. , 1984, Journal of immunology.
[18] S. Shak,et al. Prostaglandin I2 is not a major metabolite of arachidonic acid in cultured endothelial cells from human foreskin microvessels. , 1984, The Journal of clinical investigation.
[19] S. Peters,et al. Arachidonic acid metabolism in purified human lung mast cells. , 1984, Journal of immunology.
[20] J. Oates,et al. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. , 1982, Journal of immunology.
[21] G. Gleich,et al. The late phase of the immunoglobulin E-mediated reaction: a link between anaphylaxis and common allergic disease? , 1982, The Journal of allergy and clinical immunology.
[22] J. Oates,et al. Increased production of prostaglandin D2 in patients with systemic mastocytosis. , 1980, The New England journal of medicine.
[23] P. Becherer,et al. Histamine stimulates prostacyclin synthesis in cultured human umbilical vein endothelial cells , 1980 .
[24] H. Nelson,et al. An evaluation of the pharmacologic inhibition of the immediate and late cutaneous reaction to allergen , 1980 .
[25] T. J. Williams,et al. PROSTAGLANDIN E2, PROSTAGLANDIN I2 AND THE VASCULAR CHANGES OF INFLAMMATION , 1979, British journal of pharmacology.
[26] E. Jaffe,et al. Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187. , 1978, The Journal of clinical investigation.
[27] J. Vane,et al. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. , 1976, Prostaglandins.
[28] G. Solley,et al. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. , 1976, The Journal of clinical investigation.
[29] A. Kaplan,et al. In vivo studies of mediator release in cold urticaria and cholinergic urticaria. , 1975, The Journal of allergy and clinical immunology.
[30] F. Hargreave,et al. Late cutaneous allergic responses in isolated IgE-dependent reactions. , 1973, The Journal of allergy and clinical immunology.
[31] E. Spokas,et al. Hepatie Transformation of Prostaglandin Da to a New Prostanoid , 9 a , l l & Prostaglandin Fz , That Inhibits Platelet Aggregation and Constricts Blood Vessels * , 2022 .